/PRNewswire-FirstCall/ -- Arrayit Corporation (OTC Bulletin Board: ARYC), a life sciences-focused healthcare company, today announced that the Company has been selected to present at the
Personalized Medicine Conference in Silicon Valley,
Personalized Medicine focuses on the use of a patient's clinical, genetic, genomic and environmental information to select a medication and determine optimal dosage, or to choose a therapy, or recommend preventative health measures. The goal of Personalized Medicine is to optimize the healthcare and medical outcomes for each individual.
PMWC's technology showcase will feature selected companies recognized for their breakthrough products and services. The "TOP 5" presenters will move to a semi-final stage to compete for the "PMWC 2010 Most Promising Company Award." The event is being hosted by
, one of the largest angel and venture capitalist investment forums and funds in
the United States
, and will take place on
January 19-20, 2010
Arrayit founder and Executive Vice President
will present the Company's growth strategy, which includes the development of new microarray-based pre-symptomatic tests for the diagnosis of Ovarian Cancer (
), Parkinson's Disease and Prostate Cancer. The Company will market and sell its diagnostic tests through its subsidiary, Arrayit Diagnostics, Inc.
About Arrayit Diagnostics, Inc.
Arrayit Diagnostics, Inc., a majority-owned subsidiary of Arrayit Corporation, is actively engaged in developing and commercializing a series of proprietary microarray-based diagnostic tests that provide for early detection of cancers, neurodegenerative diseases and other chronic and severe disease states.
About Arrayit Corporation
Arrayit Corporation leads and empowers the genetic, research, pharmaceutical and diagnostic communities through the discovery, development and manufacture of proprietary life science technologies and consumables for disease prevention, treatment and cure. It now offers over 650 products to a customer base of more than 10,000 laboratories worldwide, including almost every major university, pharmaceutical and biotechnology company, major agricultural and chemical companies, government agencies, national research foundations and many private sector enterprises. Please visit
for more information.